0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Antithrombin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-33F6713
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Antithrombin Market Insights and Forecast to 2028
BUY CHAPTERS

Antithrombin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-33F6713
Report
September 2024
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Antithrombin - Market Size

The global market for Antithrombin was estimated to be worth US$ 512.7 million in 2023 and is forecast to a readjusted size of US$ 691.6 million by 2030 with a CAGR of 4.3% during the forecast period 2024-2030

Antithrombin - Market

Antithrombin - Market

Antithrombin is a protein in the blood that plays a crucial role in regulating blood clotting. It is a natural anticoagulant that inhibits or blocks the activity of certain clotting factors, specifically thrombin and factor Xa, preventing excessive clotting and maintaining blood flow.
Antithrombin acts by binding to these clotting factors and forming a complex, which inactivates them and prevents their ability to promote the conversion of fibrinogen into fibrin, the insoluble protein that forms blood clots. By inhibiting thrombin and factor Xa, antithrombin interrupts the clotting cascade and helps to prevent the formation of unwanted blood clots.Antithrombin is also used as a pharmacological agent in certain medical conditions, such as during surgery or in high-risk thrombotic situations, to prevent blood clot formation. It can be administered intravenously as a medication to help maintain normal blood clotting function.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antithrombin, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Antithrombin by region & country, by Type, and by Application.
The Antithrombin market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antithrombin.
Market Segmentation

Scope of Antithrombin - Market Report

Report Metric Details
Report Name Antithrombin - Market
Forecasted market size in 2030 US$ 691.6 million
CAGR 4.3%
Forecasted years 2024 - 2030
Segment by Type:
  • Liquid
  • Lyophilized
Segment by Application
  • Diagnostics
  • Therapeutics
  • Research
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Grifols, rEVO Biologics Inc., Takeda, Kedrion S.p.A., CSL Limited, Scripps Laboratories Inc., Lee Biosolutions
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Antithrombin manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Antithrombin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Antithrombin in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Antithrombin - Market size in 2030?

Ans: The Antithrombin - Market size in 2030 will be US$ 691.6 million.

Who are the main players in the Antithrombin - Market report?

Ans: The main players in the Antithrombin - Market are Grifols, rEVO Biologics Inc., Takeda, Kedrion S.p.A., CSL Limited, Scripps Laboratories Inc., Lee Biosolutions

What are the Application segmentation covered in the Antithrombin - Market report?

Ans: The Applications covered in the Antithrombin - Market report are Diagnostics, Therapeutics, Research

What are the Type segmentation covered in the Antithrombin - Market report?

Ans: The Types covered in the Antithrombin - Market report are Liquid, Lyophilized

1 Market Overview
1.1 Antithrombin Product Introduction
1.2 Global Antithrombin Market Size Forecast
1.3 Antithrombin Market Trends & Drivers
1.3.1 Antithrombin Industry Trends
1.3.2 Antithrombin Market Drivers & Opportunity
1.3.3 Antithrombin Market Challenges
1.3.4 Antithrombin Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Antithrombin Players Revenue Ranking (2023)
2.2 Global Antithrombin Revenue by Company (2019-2024)
2.3 Key Companies Antithrombin Manufacturing Base Distribution and Headquarters
2.4 Key Companies Antithrombin Product Offered
2.5 Key Companies Time to Begin Mass Production of Antithrombin
2.6 Antithrombin Market Competitive Analysis
2.6.1 Antithrombin Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Antithrombin Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antithrombin as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Liquid
3.1.2 Lyophilized
3.2 Global Antithrombin Sales Value by Type
3.2.1 Global Antithrombin Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Antithrombin Sales Value, by Type (2019-2030)
3.2.3 Global Antithrombin Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Diagnostics
4.1.2 Therapeutics
4.1.3 Research
4.2 Global Antithrombin Sales Value by Application
4.2.1 Global Antithrombin Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Antithrombin Sales Value, by Application (2019-2030)
4.2.3 Global Antithrombin Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Antithrombin Sales Value by Region
5.1.1 Global Antithrombin Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Antithrombin Sales Value by Region (2019-2024)
5.1.3 Global Antithrombin Sales Value by Region (2025-2030)
5.1.4 Global Antithrombin Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Antithrombin Sales Value, 2019-2030
5.2.2 North America Antithrombin Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Antithrombin Sales Value, 2019-2030
5.3.2 Europe Antithrombin Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Antithrombin Sales Value, 2019-2030
5.4.2 Asia Pacific Antithrombin Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Antithrombin Sales Value, 2019-2030
5.5.2 South America Antithrombin Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Antithrombin Sales Value, 2019-2030
5.6.2 Middle East & Africa Antithrombin Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Antithrombin Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Antithrombin Sales Value
6.3 United States
6.3.1 United States Antithrombin Sales Value, 2019-2030
6.3.2 United States Antithrombin Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Antithrombin Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Antithrombin Sales Value, 2019-2030
6.4.2 Europe Antithrombin Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Antithrombin Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Antithrombin Sales Value, 2019-2030
6.5.2 China Antithrombin Sales Value by Type (%), 2023 VS 2030
6.5.3 China Antithrombin Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Antithrombin Sales Value, 2019-2030
6.6.2 Japan Antithrombin Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Antithrombin Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Antithrombin Sales Value, 2019-2030
6.7.2 South Korea Antithrombin Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Antithrombin Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Antithrombin Sales Value, 2019-2030
6.8.2 Southeast Asia Antithrombin Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Antithrombin Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Antithrombin Sales Value, 2019-2030
6.9.2 India Antithrombin Sales Value by Type (%), 2023 VS 2030
6.9.3 India Antithrombin Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Grifols
7.1.1 Grifols Profile
7.1.2 Grifols Main Business
7.1.3 Grifols Antithrombin Products, Services and Solutions
7.1.4 Grifols Antithrombin Revenue (US$ Million) & (2019-2024)
7.1.5 Grifols Recent Developments
7.2 rEVO Biologics Inc.
7.2.1 rEVO Biologics Inc. Profile
7.2.2 rEVO Biologics Inc. Main Business
7.2.3 rEVO Biologics Inc. Antithrombin Products, Services and Solutions
7.2.4 rEVO Biologics Inc. Antithrombin Revenue (US$ Million) & (2019-2024)
7.2.5 rEVO Biologics Inc. Recent Developments
7.3 Takeda
7.3.1 Takeda Profile
7.3.2 Takeda Main Business
7.3.3 Takeda Antithrombin Products, Services and Solutions
7.3.4 Takeda Antithrombin Revenue (US$ Million) & (2019-2024)
7.3.5 Kedrion S.p.A. Recent Developments
7.4 Kedrion S.p.A.
7.4.1 Kedrion S.p.A. Profile
7.4.2 Kedrion S.p.A. Main Business
7.4.3 Kedrion S.p.A. Antithrombin Products, Services and Solutions
7.4.4 Kedrion S.p.A. Antithrombin Revenue (US$ Million) & (2019-2024)
7.4.5 Kedrion S.p.A. Recent Developments
7.5 CSL Limited
7.5.1 CSL Limited Profile
7.5.2 CSL Limited Main Business
7.5.3 CSL Limited Antithrombin Products, Services and Solutions
7.5.4 CSL Limited Antithrombin Revenue (US$ Million) & (2019-2024)
7.5.5 CSL Limited Recent Developments
7.6 Scripps Laboratories Inc.
7.6.1 Scripps Laboratories Inc. Profile
7.6.2 Scripps Laboratories Inc. Main Business
7.6.3 Scripps Laboratories Inc. Antithrombin Products, Services and Solutions
7.6.4 Scripps Laboratories Inc. Antithrombin Revenue (US$ Million) & (2019-2024)
7.6.5 Scripps Laboratories Inc. Recent Developments
7.7 Lee Biosolutions
7.7.1 Lee Biosolutions Profile
7.7.2 Lee Biosolutions Main Business
7.7.3 Lee Biosolutions Antithrombin Products, Services and Solutions
7.7.4 Lee Biosolutions Antithrombin Revenue (US$ Million) & (2019-2024)
7.7.5 Lee Biosolutions Recent Developments
8 Industry Chain Analysis
8.1 Antithrombin Industrial Chain
8.2 Antithrombin Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Antithrombin Sales Model
8.5.2 Sales Channel
8.5.3 Antithrombin Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Antithrombin Market Trends
    Table 2. Antithrombin Market Drivers & Opportunity
    Table 3. Antithrombin Market Challenges
    Table 4. Antithrombin Market Restraints
    Table 5. Global Antithrombin Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Antithrombin Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Antithrombin Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Antithrombin Product Type
    Table 9. Key Companies Time to Begin Mass Production of Antithrombin
    Table 10. Global Antithrombin Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antithrombin as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Antithrombin Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Antithrombin Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Antithrombin Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Antithrombin Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Antithrombin Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Antithrombin Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Antithrombin Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Antithrombin Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Antithrombin Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Antithrombin Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Antithrombin Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Antithrombin Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Antithrombin Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Antithrombin Sales Value by Region (2019-2024) & (%)
    Table 27. Global Antithrombin Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Antithrombin Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Antithrombin Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Antithrombin Sales Value, (2025-2030) & (US$ Million)
    Table 31. Grifols Basic Information List
    Table 32. Grifols Description and Business Overview
    Table 33. Grifols Antithrombin Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Antithrombin Business of Grifols (2019-2024)
    Table 35. Grifols Recent Developments
    Table 36. rEVO Biologics Inc. Basic Information List
    Table 37. rEVO Biologics Inc. Description and Business Overview
    Table 38. rEVO Biologics Inc. Antithrombin Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Antithrombin Business of rEVO Biologics Inc. (2019-2024)
    Table 40. rEVO Biologics Inc. Recent Developments
    Table 41. Takeda Basic Information List
    Table 42. Takeda Description and Business Overview
    Table 43. Takeda Antithrombin Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Antithrombin Business of Takeda (2019-2024)
    Table 45. Takeda Recent Developments
    Table 46. Kedrion S.p.A. Basic Information List
    Table 47. Kedrion S.p.A. Description and Business Overview
    Table 48. Kedrion S.p.A. Antithrombin Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Antithrombin Business of Kedrion S.p.A. (2019-2024)
    Table 50. Kedrion S.p.A. Recent Developments
    Table 51. CSL Limited Basic Information List
    Table 52. CSL Limited Description and Business Overview
    Table 53. CSL Limited Antithrombin Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Antithrombin Business of CSL Limited (2019-2024)
    Table 55. CSL Limited Recent Developments
    Table 56. Scripps Laboratories Inc. Basic Information List
    Table 57. Scripps Laboratories Inc. Description and Business Overview
    Table 58. Scripps Laboratories Inc. Antithrombin Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Antithrombin Business of Scripps Laboratories Inc. (2019-2024)
    Table 60. Scripps Laboratories Inc. Recent Developments
    Table 61. Lee Biosolutions Basic Information List
    Table 62. Lee Biosolutions Description and Business Overview
    Table 63. Lee Biosolutions Antithrombin Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Antithrombin Business of Lee Biosolutions (2019-2024)
    Table 65. Lee Biosolutions Recent Developments
    Table 66. Key Raw Materials Lists
    Table 67. Raw Materials Key Suppliers Lists
    Table 68. Antithrombin Downstream Customers
    Table 69. Antithrombin Distributors List
    Table 70. Research Programs/Design for This Report
    Table 71. Key Data Information from Secondary Sources
    Table 72. Key Data Information from Primary Sources
    Table 73. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Antithrombin Product Picture
    Figure 2. Global Antithrombin Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Antithrombin Sales Value (2019-2030) & (US$ Million)
    Figure 4. Antithrombin Report Years Considered
    Figure 5. Global Antithrombin Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Antithrombin Revenue in 2023
    Figure 7. Antithrombin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Liquid Picture
    Figure 9. Lyophilized Picture
    Figure 10. Global Antithrombin Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Antithrombin Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Diagnostics
    Figure 13. Product Picture of Therapeutics
    Figure 14. Product Picture of Research
    Figure 15. Global Antithrombin Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Antithrombin Sales Value Market Share by Application, 2023 & 2030
    Figure 17. North America Antithrombin Sales Value (2019-2030) & (US$ Million)
    Figure 18. North America Antithrombin Sales Value by Country (%), 2023 VS 2030
    Figure 19. Europe Antithrombin Sales Value (2019-2030) & (US$ Million)
    Figure 20. Europe Antithrombin Sales Value by Country (%), 2023 VS 2030
    Figure 21. Asia Pacific Antithrombin Sales Value (2019-2030) & (US$ Million)
    Figure 22. Asia Pacific Antithrombin Sales Value by Country (%), 2023 VS 2030
    Figure 23. South America Antithrombin Sales Value (2019-2030) & (US$ Million)
    Figure 24. South America Antithrombin Sales Value by Country (%), 2023 VS 2030
    Figure 25. Middle East & Africa Antithrombin Sales Value (2019-2030) & (US$ Million)
    Figure 26. Middle East & Africa Antithrombin Sales Value by Country (%), 2023 VS 2030
    Figure 27. Key Countries/Regions Antithrombin Sales Value (%), (2019-2030)
    Figure 28. United States Antithrombin Sales Value, (2019-2030) & (US$ Million)
    Figure 29. United States Antithrombin Sales Value by Type (%), 2023 VS 2030
    Figure 30. United States Antithrombin Sales Value by Application (%), 2023 VS 2030
    Figure 31. Europe Antithrombin Sales Value, (2019-2030) & (US$ Million)
    Figure 32. Europe Antithrombin Sales Value by Type (%), 2023 VS 2030
    Figure 33. Europe Antithrombin Sales Value by Application (%), 2023 VS 2030
    Figure 34. China Antithrombin Sales Value, (2019-2030) & (US$ Million)
    Figure 35. China Antithrombin Sales Value by Type (%), 2023 VS 2030
    Figure 36. China Antithrombin Sales Value by Application (%), 2023 VS 2030
    Figure 37. Japan Antithrombin Sales Value, (2019-2030) & (US$ Million)
    Figure 38. Japan Antithrombin Sales Value by Type (%), 2023 VS 2030
    Figure 39. Japan Antithrombin Sales Value by Application (%), 2023 VS 2030
    Figure 40. South Korea Antithrombin Sales Value, (2019-2030) & (US$ Million)
    Figure 41. South Korea Antithrombin Sales Value by Type (%), 2023 VS 2030
    Figure 42. South Korea Antithrombin Sales Value by Application (%), 2023 VS 2030
    Figure 43. Southeast Asia Antithrombin Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Antithrombin Sales Value by Type (%), 2023 VS 2030
    Figure 45. Southeast Asia Antithrombin Sales Value by Application (%), 2023 VS 2030
    Figure 46. India Antithrombin Sales Value, (2019-2030) & (US$ Million)
    Figure 47. India Antithrombin Sales Value by Type (%), 2023 VS 2030
    Figure 48. India Antithrombin Sales Value by Application (%), 2023 VS 2030
    Figure 49. Antithrombin Industrial Chain
    Figure 50. Antithrombin Manufacturing Cost Structure
    Figure 51. Channels of Distribution (Direct Sales, and Distribution)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS